A. St-andre, D. Rossi, and A. , Hemodynamic management of patients in the first 24 hours after cardiac surgery, Critical Care Medicine, vol.33, issue.9, pp.2082-2093, 2005.
DOI : 10.1097/01.CCM.0000178355.96817.81

X. Sun, L. Zhang, P. Hill, R. Lowery, A. Lee et al., Is incidence of postoperative vasoplegic syndrome different between off-pump and on-pump coronary artery bypass grafting surgery?, European Journal of Cardio-Thoracic Surgery, vol.34, issue.4, pp.820-825, 2008.
DOI : 10.1016/j.ejcts.2008.07.012

M. Argenziano, A. Choudhri, M. Oz, E. Rose, C. Smith et al., A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement, Circulation, vol.96, pp.286-290, 1997.

D. Morales, D. Gregg, D. Helman, M. Williams, Y. Naka et al., Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock, The Annals of Thoracic Surgery, vol.69, issue.1, pp.102-106, 2000.
DOI : 10.1016/S0003-4975(99)01197-2

S. Jochberger, C. Velik-salchner, V. Mayr, G. Luckner, V. Wenzel et al., The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study, Intensive Care Medicine, vol.91, issue.6, pp.489-497, 2009.
DOI : 10.1007/s00134-008-1279-1

M. Argenziano, J. Chen, A. Choudhri, S. Cullinane, E. Garfein et al., Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent, The Journal of Thoracic and Cardiovascular Surgery, vol.116, issue.6, pp.973-980, 1998.
DOI : 10.1016/S0022-5223(98)70049-2

M. Dunser, A. Mayr, H. Ulmer, N. Ritsch, H. Knotzer et al., The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis, Anesth Analg, vol.93, pp.7-13, 2001.

D. Landry and J. Oliver, The pathogenesis of vasodilatory shock, N Engl J Med, vol.345, pp.588-595, 2001.

G. Luckner, M. Dünser, S. Jochberger, V. Mayr, V. Wenzel et al., Arginine vasopressin in 316 patients with advanced vasodilatory shock*, Critical Care Medicine, vol.33, issue.11, pp.2659-2666, 2005.
DOI : 10.1097/01.CCM.0000186749.34028.40

W. Pajk, W. Hasibeder, B. Friesenecker, A. Mayr, M. Dünser et al., Serum vasopressin concentrations in critically ill patients, Crit Care Med, vol.34, pp.293-299, 2006.

S. Neuhold, M. Huelsmann, G. Strunk, B. Stoiser, J. Struck et al., Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patients With Chronic Heart Failure, Journal of the American College of Cardiology, vol.52, issue.4, pp.266-272, 2008.
DOI : 10.1016/j.jacc.2008.03.050

S. Khan, O. Dhillon, O. Brien, R. Struck, J. Quinn et al., C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction. Leicester Acute Myocardial Infarction Peptide (LAMP) Study. Circulation, pp.2103-2110, 2007.

T. Nakamura, H. Funayama, A. Yoshimura, Y. Tsuruya, M. Saito et al., Possible vascular role of increased plasma arginine vasopressin in congestive heart failure, International Journal of Cardiology, vol.106, issue.2, pp.191-195, 2006.
DOI : 10.1016/j.ijcard.2005.01.043

I. Westermann, M. Dünser, T. Haas, S. Jochberger, G. Luckner et al., ENDOGENOUS VASOPRESSIN AND COPEPTIN RESPONSE IN MULTIPLE TRAUMA PATIENTS, Shock, vol.28, pp.644-649, 2007.
DOI : 10.1097/SHK.0b013e3180cab33f

N. Morgenthaler, B. Müller, J. Struck, A. Bergmann, H. Redl et al., COPEPTIN, A STABLE PEPTIDE OF THE ARGININE VASOPRESSIN PRECURSOR, IS ELEVATED IN HEMORRHAGIC AND SEPTIC SHOCK, Shock, vol.28, issue.2, pp.219-226, 2007.
DOI : 10.1097/SHK.0b013e318033e5da

A. Voors, S. Von-haehling, S. Anker, H. Hillege, J. Struck et al., C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study, European Heart Journal, vol.30, issue.10, pp.1187-1194, 2009.
DOI : 10.1093/eurheartj/ehp098

B. Stoiser, D. Mörtl, M. Hülsmann, R. Berger, J. Struck et al., Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure, European Journal of Clinical Investigation, vol.292, issue.11, pp.771-778, 2006.
DOI : 10.1016/S0014-2999(02)01972-6

D. Philbin, C. Coggins, N. Wilson, and J. Sokoloski, Antidiuretic hormone levels during cardiopulmonary bypass, J Thorac Cardiovasc Surg, vol.73, pp.145-148, 1977.

W. Woods, M. Forsling, L. Quesne, and L. , Plasma arginine vasopressin levels and arterial pressure during open heart surgery, British Journal of Surgery, vol.72, issue.1, pp.29-32, 1989.
DOI : 10.1002/bjs.1800760110

R. Landgraf, I. Neumann, F. Holsboer, and Q. Pittman, Interleukin-1?? Stimulates both Central and Peripheral Release of Vasopressin and Oxytocin in the Rat, European Journal of Neuroscience, vol.689, issue.4, pp.592-598, 1995.
DOI : 10.1111/j.1460-9568.1995.tb00663.x

J. Raber and F. Bloom, IL-2 induces vasopressin release from the hypothalamus and the amygdale: role of nitric oxide-mediated signalling, J Neurosci, vol.14, pp.6187-6195, 1994.

H. Ruthberg, E. Hakanson, B. Anderberg, L. Jorfeldt, B. Schildt et al., Thyroid hormones, catecholamine and cortisol concentrations after upper abdominal surgery, Acta Chir Scand, vol.150, pp.273-278, 1984.

T. Sharshar, R. Carlier, A. Blanchard, A. Feydy, F. Gray et al., Depletion of neurohypophyseal content of vasopressin in septic shock*, Critical Care Medicine, vol.30, issue.3, pp.497-500, 2002.
DOI : 10.1097/00003246-200203000-00001

N. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann, Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin, Clinical Chemistry, vol.52, issue.1, pp.112-119, 2006.
DOI : 10.1373/clinchem.2005.060038

J. Struck, N. Morgenthaler, and A. Bergmann, Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients, Peptides, vol.26, issue.12, pp.2500-2504, 2005.
DOI : 10.1016/j.peptides.2005.04.019

. Colson, Critical Care, pp.255-255, 2011.